VYVANSE
VYVANSE
Approved
DIN Number
02490250
Drug Class
Human
Market Date
Aug 6, 2019
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02490250
AIG Number0152536004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA I)
A
ATC Code
N06BA12 LISDEXAMFETAMINE
Product Specifications
Dosage FormTablet (Chewable)
Route of AdministrationOral
AHFS Classification28:20.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
LISDEXAMFETAMINE DIMESYLATEActive
Strength: 40 MG
Monograph: LISDEXAMFETAMINE DIMESYLATE